OTSUKA NOVEL PRODUCTS GMBH -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 92.500.000 0 1
2019 0 12.004.953 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION2
JANSSEN PHARMACEUTICA NV2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
UNIVERSITA DEGLI STUDI DI MILANO2
UNIVERSITA VITASALUTE SAN RAFFAELE2
ALLERGAN LIMITED1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTRAZENECA1
BERRY CONSULTANTS LLP1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHILDREN'S TUMOR FOUNDATION1
CRITICAL PATH INSTITUTE LIMITED1
CUSTODIX NV1
DEUTSCHES ZENTRUM FUR INFEKTIONSFORSCHUNG EV1
DOCUMENTAL OU1
EATRIS ERIC1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EUROPEAN LUNG FOUNDATION1
EUROPEAN RESPIRATORY SOCIETY1
EUROSCAN INTERNATIONAL NETWORK EV1
FORSCHUNGSZENTRUM BORSTEL1
FORUM DES PATIENTS EUROPEENS1
FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUTO DE SAUDE PUBLICA DA UNIVERSIDADE DO PORTO1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KING'S COLLEGE LONDON1
KLINIKUM DER UNIVERSITAT MUNCHEN1
KONINKLIJKE NEDERLANDSE CENTRALE VERENIGING TOT BESTRIJDING DER TUBERCULOSE1
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER1
LUNGS EUROPE1
MEDIZINISCHE UNIVERSITAET WIEN1
NOVARTIS PHARMA1
NOVO NORDISK1
PFIZER LIMITED1
SANOFIAVENTIS1
SPRINGWORKS THERAPEUTICS INC1
STICHTING LYGATURE1
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TASK FOUNDATION NPC1
TEAM IT RESEARCH SL1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED1
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA1
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA1
THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF MANCHESTER1
TUBERCULOSIS NETWORK EUROPEAN TRIALSGROUP EV1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF HAMBURG1
UNIVERSITY OF LANCASTER1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UPPSALA UNIVERSITET1

Constancy:

Total number of partners: 67
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 67
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-06-01ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS UNITE4TBparticipant92.500.00032
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337